KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Net Income (2018 - 2025)

Historic Net Income for ClearPoint Neuro (CLPT) over the last 13 years, with Q3 2025 value amounting to -$5.9 million.

  • ClearPoint Neuro's Net Income fell 1843.59% to -$5.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$23.4 million, marking a year-over-year decrease of 2834.27%. This contributed to the annual value of -$19.7 million for FY2024, which is 1202.89% up from last year.
  • ClearPoint Neuro's Net Income amounted to -$5.9 million in Q3 2025, which was down 1843.59% from -$5.8 million recorded in Q2 2025.
  • In the past 5 years, ClearPoint Neuro's Net Income registered a high of -$2.5 million during Q1 2021, and its lowest value of -$7.1 million during Q2 2023.
  • Moreover, its 5-year median value for Net Income was -$4.5 million (2022), whereas its average is -$4.7 million.
  • In the last 5 years, ClearPoint Neuro's Net Income plummeted by 15829.39% in 2021 and then skyrocketed by 3818.54% in 2024.
  • ClearPoint Neuro's Net Income (Quarter) stood at -$4.0 million in 2021, then decreased by 12.23% to -$4.5 million in 2022, then fell by 5.3% to -$4.7 million in 2023, then fell by 20.02% to -$5.6 million in 2024, then dropped by 4.3% to -$5.9 million in 2025.
  • Its last three reported values are -$5.9 million in Q3 2025, -$5.8 million for Q2 2025, and -$6.0 million during Q1 2025.